FIELD: medicine.
SUBSTANCE: invention relates to the levorotatory enantiomer of 2-ethyl-6-methyl-3-hydroxypyridinium L-hydroxyethane butanedionate which possesses cerebroprotective activity and prolongs the period of bioelectrical activity of the myocardium. 
.
EFFECT: new compound that can be used in medicine as a cerebroprotective agent.
1 cl, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT EXHIBITING HEPATOPROTECTIVE, LIPID-REGULATING, ANTIISCHEMIC AND NEUROTROPIC ACTIVITY | 2018 |
|
RU2705575C1 |
| COMPLEX SALTS OF ACIDUM ACEXAMICUM, STIMULATING REGENERATION OF BONE TISSUE, ACCELERATING PROCESSES OF REPARATIVE OSTEOGENESIS, STIMULATING MINERALIZATION OF BONE TISSUE IN OSTEOPOROSIS | 2018 |
|
RU2668966C1 |
| NOVEL 3-HYDROXYPYRIDINE DERIVATIVE HAVING LIPID REGULATING ACTIVITY | 2020 |
|
RU2743923C1 |
| ANTIOXIDANT AND ANTIHYPOXIC AGENT OF 6-METHYL-2-ETHYL-3-HYDROHYPYRIDINE SUCCINATE | 2008 |
|
RU2398583C2 |
| NEUROTROPIC PREPARATION, POSSESSING ANTI-HYPOXIC, NEUROPROTECTIVE, ANTI-AMNESTIC AND VESTIBULAR-PROTECTIVE ACTIVITY | 2014 |
|
RU2547728C1 |
| ZINC ACETATE COMPLEX WITH 3-HYDROXYPYRIDINE WITH ANTI-HYPOXIC ACTIVITY UNDER CONDITIONS OF ACUTE EXOGENOUS HYPOXIA | 2016 |
|
RU2631496C1 |
| 2-ETHYL-6-METHYL-3-HYDROXYLIRIDINIUMHYDROXYBUTANEDIOAT EXPRESSING ANTI-ISHEMIC, CEREBROPROTECTIVE, NEUROTROPIC AND LIPID-REGULATING ACTIVITY, PHARMACEUTICAL COMPOSITIONS AND MEDICAL PRODUCT | 2008 |
|
RU2377237C1 |
| USE OF A PHARMACEUTICAL COMPOSITION WITH ANTIOXIDANT, VIRUCIDAL, IMMUNOSTULATING, ANTIHYPOXIC AND ANTI-AGGREGANT EFFECT | 2023 |
|
RU2808445C1 |
| TETRAPEPTIDE AND PREPARATION, POSSESSING CEREBROPROTECTIVE AND ANTIAMNESTIC ACTIVITIES (VERSIONS) | 2013 |
|
RU2537560C2 |
| COMPLEX COMPOUND OF 6-METHYLURACIL WITH SUCCINIC ACID ELICITING ANTIHYPOXIC ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2259357C2 |
